ATI Inc. 2022 Third-Quarter Form 10-Q Summary
Business Context and Reporting Period
ATI Inc. is a global manufacturer of specialty materials and complex components, operating through High Performance Materials & Components (HPMC) and Advanced Alloys & Solutions (AA&S). The filing covers the quarter and nine months ended September 30, 2022, with comparisons to the prior-year periods. Aerospace and defense represented 51% of third-quarter sales and 48% of nine-month sales.
Key Financial Metrics
| Metric | Q3 2022 | Q3 2021 | 9M 2022 | 9M 2021 |
|---|---|---|---|---|
| Sales | $1,032.0 million | $725.7 million | $2,825.6 million | $2,034.4 million |
| Gross profit | $183.8 million | $82.5 million | $528.5 million | $211.0 million |
| Gross margin | 17.8% | 11.4% | 18.7% | 10.4% |
| Operating income | $113.2 million | $29.9 million | $178.6 million | $50.4 million |
| Net income attributable to ATI | $61.1 million | $48.7 million | $54.0 million | $(8.4) million |
| Diluted EPS | $0.42 | $0.35 | $0.42 | $(0.07) |
| Adjusted EBITDA | $141.1 million | $79.9 million | $409.2 million | $196.2 million |
- Q3 segment EBITDA was $161.6 million, or 15.7% of sales, versus $94.2 million, or 13.0%, in the prior-year quarter. Nine-month segment EBITDA was $469.9 million, or 16.6%, versus $241.7 million, or 11.9%.
- Net cash used in operating activities was $99.4 million for the first nine months, improving from $244.8 million used in the prior-year period. Working-capital investment remained significant, including increases in receivables and inventories.
- Capital expenditures were $100.5 million for the first nine months, compared with $104.2 million in 2021.
- Cash and cash equivalents were $329.1 million at September 30, 2022, down from $687.7 million at December 31, 2021.
- Total debt was $1.729 billion, excluding debt issuance costs, versus $1.843 billion at year-end 2021. Net debt was $1.418 billion. ATI reported a trailing net-debt-to-Adjusted-EBITDA ratio of 2.81x versus 4.04x at year-end 2021.
- Liquidity included approximately $550 million of additional availability under the ABL facility. No borrowings were outstanding under the revolving ABL portion, although $40.8 million supported letters of credit.
Material Changes Versus Prior Comparable Period
- Sales increased 42% in Q3 and 39% in the first nine months, driven primarily by commercial aerospace recovery, higher aerospace airframe demand, improved energy sales, and higher pricing and raw-material pass-through mechanisms.
- HPMC Q3 sales increased 53% and segment EBITDA margin rose to 18.8% from 12.5%, primarily from higher commercial jet-engine demand and improved facility utilization.
- AA&S Q3 sales increased 35%, while EBITDA margin was broadly unchanged at 13.2% versus 13.3%; stronger product mix was offset by lower raw-material surcharges and COVID-related disruption at the STAL facility in China.
- The prior-year quarter included $22.9 million of strike-related costs and a $64.9 million retirement-benefit settlement gain, making year-over-year comparisons unusual.
- Nine-month 2022 results included a $141.0 million loss on the sale of Sheffield, UK operations, partially offset by a $6.8 million gain on the sale of Pico Rivera assets. The Sheffield transaction was completed May 12, 2022.
- ATI recorded a $28.5 million litigation reserve related to the US Magnesium dispute, including $19.9 million in Q3, with payment expected in Q4 2022.
- ATI repurchased 4.0 million shares for $104.9 million during the first nine months under a $150 million authorization. Approximately $45.1 million remained available at September 30.
- During Q2, $82.5 million of 2022 convertible notes were converted into 5.7 million shares, with the remaining $1.7 million paid in cash.
Guidance, Outlook, Risks, and Unusual Items
- Management expected continued strong commercial aerospace demand in Q4 2022. AA&S sales were expected to be sequentially lower due to falling raw-material surcharges and planned operating rates intended to reduce managed working capital.
- Management cited longer-term opportunities in commercial aerospace airframe and jet-engine products, including potential supply-chain repositioning related to the Russia-Ukraine conflict.
- Raw-material availability was described as adequate, but commodity-price movements and timing differences in index pricing could create margin volatility. ATI hedged approximately 75% of forecast domestic natural-gas requirements for the remainder of 2022, 50% for 2023, and 15% for 2024.
- Key risks include the Russia-Ukraine conflict and related sanctions, supply-chain interruptions, commodity and energy-price volatility, COVID-19 impacts, Chinese operating disruptions, labor disputes, equipment outages, pension funding requirements, environmental liabilities, litigation, and foreign-exchange exposure.
- Environmental remediation reserves were approximately $13 million, with reasonably possible costs above recorded reserves of up to $16 million.
- ATI expects the Uniti titanium joint venture with Russian-based VSMPO to be dissolved in early 2023; no impairment was recorded as of September 30, 2022.
- The company maintained valuation allowances on U.S. federal and state deferred tax assets because of its cumulative U.S. loss position. Management did not expect significant U.S. federal or state cash taxes in the next several years due to net operating-loss carryforwards.
- The ABL facility was amended in September 2022, extending maturity to September 2027 and increasing revolving capacity to $600 million. ATI was in compliance with its fixed-charge coverage covenant at quarter-end.
Most Important Facts for Investors to Verify
- Whether commercial aerospace demand and production-rate increases continue to support revenue growth and HPMC margin expansion.
- Whether working-capital investment converts into operating cash flow, particularly receivables and the elevated inventory balance of $1.217 billion.
- The timing and cash impact of the $28.5 million US Magnesium settlement and other environmental or litigation exposures.
- Progress in reducing leverage while funding capital expenditures, share repurchases, pension obligations, and 2025 debt maturities.
- The extent to which government COVID-relief benefits of $34.3 million included in nine-month 2022 segment EBITDA are nonrecurring.
- Potential effects of Russia-Ukraine-related sanctions, raw-material availability, energy prices, China-related disruptions, and the planned Uniti dissolution.